FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 34 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $22,000 | -76.8% | 3,068 | -79.8% | 0.00% | – |
| Q1 2021 | $95,000 | -22.8% | 15,201 | -8.0% | 0.00% | – |
| Q4 2020 | $123,000 | +66.2% | 16,527 | +35.2% | 0.00% | – |
| Q3 2020 | $74,000 | -20.4% | 12,225 | +9.4% | 0.00% | – |
| Q2 2020 | $93,000 | +933.3% | 11,174 | +702.2% | 0.00% | – |
| Q4 2019 | $9,000 | -18.2% | 1,393 | -50.4% | 0.00% | – |
| Q2 2019 | $11,000 | -95.0% | 2,810 | -93.9% | 0.00% | – |
| Q1 2019 | $222,000 | +133.7% | 46,141 | +206.2% | 0.00% | – |
| Q4 2018 | $95,000 | -76.5% | 15,068 | -69.6% | 0.00% | – |
| Q3 2018 | $405,000 | -30.3% | 49,512 | -11.3% | 0.00% | – |
| Q2 2018 | $581,000 | +67.0% | 55,813 | +93.7% | 0.00% | – |
| Q1 2018 | $348,000 | +5700.0% | 28,811 | +4670.0% | 0.00% | – |
| Q4 2017 | $6,000 | – | 604 | +11980.0% | 0.00% | – |
| Q3 2017 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 867,857 | $6,327,000 | 4.44% |
| Sonic Fund II, L.P. | 2,433,230 | $17,738,000 | 1.31% |
| DG Capital Management, LLC | 588,773 | $4,292,000 | 0.93% |
| Southpoint Capital Advisors LP | 4,077,214 | $29,723,000 | 0.52% |
| HARBERT FUND ADVISORS, INC. | 120,851 | $881,000 | 0.49% |
| 683 Capital Management, LLC | 1,110,000 | $8,091,000 | 0.28% |
| Avoro Capital Advisors LLC | 1,670,000 | $12,174,000 | 0.21% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $292,000 | 0.16% |
| Tibra Equities Europe Ltd | 46,300 | $338,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 68,724 | $501,000 | 0.06% |